Abstract:Background: Over-expression of vascular endothelial growth factor receptors (VEGFRs) leads to the hyperactivation of oncogenes. For inhibition of this hyperactivation, the USA Food Drug Administration (FDA) has approved many drugs that show adverse effects, such as hypertension, hypothyroidism, etc. There is a need to discover potent natural compounds that show minimal side effects. In the present study, we have taken structurally diverse known VEGFR2 inhibitors to develop a quantitative structure-activity relationship (QSAR) model and used this model to predict the inhibitory activity of natural compounds for VEGFR2. background: Over-expression of Vascular Endothelial Growth Factor Receptors (VEGFRs) leads to the hyper activation of oncogenes. For inhibition of this hyper activation, FDA has approved many drugs which show adverse effects such as hypertension, hypothyroid, fatigue, etc. There is a need to discover potent novel natural compounds that show minimal side effects. In the present study, we have taken structurally diverse known VEGFR2 inhibitors to prepare a QSAR model and used this model to predict inhibitory activity of natural compounds for VEGFR2. Methods: The QSAR model was developed through the forward stepwise multiple linear regression (MLR) method. A developed QSAR model was used to predict the inhibitory activity of natural compounds. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) assessment and molecular docking studies were performed. The binding stability of the natural compounds with VEGFR2 was elucidated through molecular dynamics (MD) simulation. objective: Structure-Activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds Results: The developed QSAR model against VEGFR2 showed the regression coefficient of the training dataset (r2) to be 0.81 and the external regression coefficient of the test dataset (r2 pred) to be 0.71. Descriptors, viz., electro-topological state of potential hydrogen bonds (maxHBint2, nHBint6), atom types (minssNH), maximum topological distance matrix (SpMAD_Dt), and 2D autocorrelation (ATSC7v), have been identified. Using this model, 14 natural compounds have been selected that have shown inhibitory activity for VEGFR2, of which six natural compounds have been found to possess a strong binding affinity with VEGFR2. In MD simulation, four complexes have shown binding stability up to 10ns. Conclusion: The developed QSAR model has identified 5 conserved activity-inducing physiochemical properties, which have been found to be correlated with the anticancer activity of the nonidentical ligand molecules bound with the VEGFR2 kinase. Lavendustin_A, 3’-O-acetylhamaudol, and arctigenin have been obtained as possible lead natural compounds against the VEGFR2 kinase.

Quantitative Structure–Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads

Machine Learning-Based QSAR Modeling, Molecular Docking, Dynamics Simulation Studies for Cytotoxicity Prediction in MDA-MB231 Triple-Negative Breast Cancer Cell Line

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Molecular modelling of antiproliferative inhibitors based on SMILES descriptors using Monte-Carlo method, docking, MD simulations and ADME/Tox studies

A QSAR Study and Molecular Design of Benzothiazole Derivatives As Potent Anticancer Agents

Enhanced Replacement Method‐based Quantitative Structure–Activity Relationship Modeling and Support Vector Machine Classification of 4‐anilino‐3‐quinolinecarbonitriles As Src Kinase Inhibitors

2D/3D-QSAR STUDY ON ANALOGUES OF 2-METHOXYESTRADIOL WITH ANTICANCER ACTIVITY

Quantitative Structure-Antitumor Activity Relationships Of Camptothecin Analogues: Cluster Analysis And Genetic Algorithm-Based Studies

Structure-activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds

A breast cancer-specific combinational QSAR model development using machine learning and deep learning approaches

A Linear and Nonlinear QSAR Analysis of Benzimidazole Derivative XY123 in Prostate Cancer Treatment

Quantitative structure-electrochemistry relationship modeling of a series of anticancer agents using MLR and ANN approaches

First report on exploration of structural features of natural compounds (NPACT database) for anti-breast cancer activity (MCF-7): QSAR-based virtual screening, molecular docking, ADMET, MD simulation, and DFT studies

3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line

2D and 3D‐QSAR Studies on Antiproliferative Thiazolidine Analogs

Quantitative structure activity relationship (QSAR) of cardiac glycosides: the development of predictive in vitro cytotoxic activity model

Theoretical investigation on QSAR of (2-Methyl-3-biphenylyl) methanol analogs as PD-L1 inhibitor

QSAR modeling for cytotoxicity of sulfur-containing Shikonin oxime derivatives targeting HCT-15, MGC-803, BEL-7402, and MCF-7 cell lines

2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives

Three dimensional quantitative structure-activity relationship study of Mcl-1 inhibitors

Qsar and Molecular Design of Benzo[B] Acronycine Derivatives As Antitumor Agents